Description
2-AminobenzonitrileMarket Outlook, 2026-2035 forecast; 2036-2047 scenarios
Evidence-led market analysis connecting supply, demand, pricing, trade, participants and commercial opportunities.
Market overview
2-Aminobenzonitrile (anthranilonitrile, CAS 1885-29-6) is a bifunctional aromatic building block whose ortho amino and nitrile groups cyclise readily to quinazolines, quinazolinones and acridines. It is used in pharmaceutical intermediates (including tacrine-type and quinazoline scaffolds), agrochemicals, dyes and functional materials. Supply is mainly from Chinese and Indian fine-chemical producers, with pricing set by 2-nitrobenzonitrile or anthranilamide routes.
The question this report answers
Which pharmaceutical and agrochemical intermediates use 2-aminobenzonitrile and who supplies them?
Market Krystal preliminary estimate (2025)
No published size. Assuming 500-1,500 t at USD 10-18/kg, we estimate USD 5-25 mn. Confidence grade C: no reliable published figure; range built from the stated assumptions and narrowed in the full report.
Market dynamics
– Demand: quinazoline APIs, dyes, agrochemicals
– Supply: China and India
– Price and margin: tied to benzonitrile and nitration costs
– Regulation: standard
Key figures at a glance (third-party, cited)
– No reliable standalone market size is published; demand is spread across many small pharmaceutical and agrochemical intermediates
– Closest parent-market anchor: benzonitrile at USD 145.0 mn in 2025, growing at 5.2% CAGR (Reports and Data)
Recent developments among key stakeholders
– No major company-specific announcements for this CAS were identified in public sources for 2025-2026; the report tracks producer activity through customs data, regulatory filings and supplier interviews
What this means for the market
Demand is fragmented across many small APIs; the report identifies the largest downstream products.
How published estimates compare
Most publicly listed 2-aminobenzonitrile reports are templated listings without sourcing. Market Krystal builds demand from identified downstream products, supplier capacity and customs data, and gives an explicit confidence range rather than a single-point figure.
Strategic scenarios to 2047
– Base: crop-protection and generic-drug volumes grow with food demand and patent expiries; intermediates follow their downstream actives, with China and India as main producers.
– Constrained supply: Chinese environmental inspections, export restrictions or Western ‘China-plus-one’ rules tighten intermediate supply; qualified Indian and Western sources gain share and pricing.
– Technology transition: new actives, biologicals and regulatory bans retire older molecules, so demand for a given intermediate can fall sharply when its downstream product loses registration or patent protection.
The swing factor for 2-Aminobenzonitrile is quinazoline API demand. Signposts: EU and US re-registration decisions, patent expiries, Chinese production curbs, India PLI investments.
What this report delivers
Annual volume (tonnes) and value (USD) for 2026-2035, segmented by application: quinazoline/quinazolinone APIs, agrochemicals, dyes and pigments, materials; grade: >98%, >99%; region: China, India, Europe, North America, Japan. Each segment is backed by a producer capacity table, price benchmarks for 2020-2025 by grade and region, trade-flow analysis and a supplier risk map. Companies assessed include Chinese and Indian nitrile fine-chemical producers, Tokyo Chemical Industry, Merck KGaA, Thermo Fisher Scientific. The 2036-2047 outlook uses three explicit scenarios (base, constrained supply and technology transition) rather than a single extrapolated curve.
Who uses this report
Agrochemical and pharmaceutical process teams, CDMOs, intermediate producers in India and China, and sourcing managers.
Why our approach is evidence-based
Most CAS-level market listings publish a single number with no audit trail, and we regularly find figures that contradict their own growth rates or exceed the size of the market they sit inside. Market Krystal works the other way round. We start from physical evidence: plant capacities, production and trade data, company disclosures, regulatory texts and price records. We build volume and price separately and only then compute value. Every third-party figure is cited, every Market Krystal estimate is labelled with its method and a confidence grade, and conflicts between sources are shown rather than hidden. Confidence grades: A = two or more independent sources agree, or government or company data; B = one published estimate checked against volumes or prices; C = no reliable published figure, so the range is built from stated assumptions and narrowed in the full report.
Methodology and delivery
Prepared by the Market Krystal Chemicals Research Team. Each report is built around the buyer’s question: after purchase, a short scope confirmation fixes the priority regions, companies and applications, and the report is delivered within 5-7 business days with the Excel model behind every estimate, so buyers can audit and change the assumptions.
The purchased delivery includes the PDF report, Excel datasets and customization around the buyer’s priority region, company set, application or commercial question.
What this research answers
The study connects production routes, named suppliers, applications, regional demand, trade, pricing drivers and commercial opportunities for this CAS number. Detailed estimates and company analysis remain inside the purchased report.
Table of contents
- 1. Executive summary: key findings, figures and Market Krystal view
- 2. Chemical identity, grades, specifications and CAS scope
- 3. Production routes, raw materials and cost structure
- 4. Global producers, plant sites and capacity
- 5. Demand by application and end market
- 6. Regional demand, trade flows and price differentials
- 7. Pricing history 2020-2025 and procurement benchmarks
- 8. Competitive landscape and company profiles
- 9. Regulation, EHS and substitution risk
- 10. Route economics: nitro reduction vs. amide dehydration
- 11. Downstream product mapping
- 12. Price benchmarks by grade and volume
- 13. Market Krystal estimate, evidence log and reconciliation with published estimates
- 14. Forecast 2026-2035: volume and value by segment and region
- 15. Scenarios 2036-2047: base, constrained supply and technology transition
- 16. Strategic recommendations and commercial opportunities
- 17. Methodology, sources and assumptions
How the research is built
Company releases, filings, regulatory material, customs and trade information, patents and documented market signals support the analysis. Disclosed facts are separated from Market Krystal estimates and scenario assumptions.
The delivery can be customized around a region, supplier set, application, customer universe or sourcing decision.
What this research is designed to answer
- Who produces the molecule, where, and at what supported capacity?
- How can capacity changes alter regional supply balances?
- Which feedstocks and operating variables move producer economics?
- Which applications and end users drive incremental demand?
- How should buyers approach sourcing and contract decisions?
- Where are the strongest market-entry and partnership opportunities?
BUILT AROUND YOUR DECISION
Need a specific company, region or customer question answered?
Request the sample and tell us the commercial decision behind your research. We will confirm the relevant scope before delivery.
REQUEST REPORT SAMPLE
Reviews
There are no reviews yet.